Burkholderia cepacia: An unusual cause of postoperative endophthalmitis

Asian Journal of Ophthalmology

Volumn 8, Issue 3, 2006, Pages 121-123

  Yilmaz, Turgut ^a,d   Celik, Ilhami ^b   Cihangiroglu, Mustafa ^b   Yildirim, Suleyman ^c   Akbulut, Ayhan ^b  

^a Department of Ophthalmology ^*  (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c State Hospital   (Turkey)

^d FIRAT UNIVERSITY   (Turkey)

Author keywords

Burkholderia cepacia; Endophthalmitis; Therapeutics

Indexed keywords

EID: 34047168725     PISSN: 15602133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Aaberg TM Jr, Flynn HW Jr, Schiffman J, et al. Nosocomial acuteonset postoperative endophthalmitis survey. Ophthalmology. 1998;105: 1004-10.
2. Santos FM, Canica MM, Bacelar MJ. Pseudomonas cepacia: the sensitivity of nosocomial strains to new antibiotics. J Int Med Res. 1985;13: 270-5.
3. Mohr CD, Tomich M, Herfst CA. Cellular aspects of Burkholderia cepacia infection. Microbes Infect. 2001;3:425-35.
4. Perera N, Palasuntheram C. The isolation of Burkholderia cepacia in a hospital setting in Sri Lanka. Ceylon Med J. 2000;45:116-8.
5. Mamalis N, Kearsley L, Brinton E. Postoperative endophthalmitis. Curr Opin Ophthalmol. 2002;13:14-8.
6. Montan PG, Koranyi G, Setterquist HE, et al. Endophthalmitis after cataract surgery: risk factors relating to technique and events of the operation and patient history. A retrospective case control study. Ophthalmology. 1998;105:2171-7.
7. Coenye T, Vandamme P, Govan JRW, et al. Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol. 2001;39: 3427-36.
8. Rapkin R. Pseudomonas espacia in the intensive care nursery. Pediatrics. 1976;57:39-43.
9. Enderer GM, Matsen JM. Colonization and infection with Pseudomonas cepacia. J Infect Dis. 1972;135:613-7.
10. Pallent LJ, Hugo WB, Grant DJ, et al. Pseudomonas cepacia as contaminant and infective agent. J Hosp Infect. 1983;4:9-13.
11. LiPuma JJ, Dasen SE, Nielson DW, et al. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet. 1990;336:1094-6.
12. Panlilio AL, Beck-Sague CM, Siegel JD, et al: Infections and pseudoinfections due to povidone-iodine solution contaminated with Pseudomonas cepacia. Clin Infect Dis. 1992;14:1078-83.
13. Sobel JD, Hashman N, Reinherz G, et al: Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med. 1982;73:183-6.
14. Lipuma JJ. Update on the Burkholderia cepacia complex. Curr Opin Pulm Med. 2005;11:528-33.
15. Ritterband D, Shah M, Cohen K, et al. Burkholderia gladioli keratitis associated with consecutive recurrent endophthalmitis. Cornea. 2002; 21:602-3.
16. Del Piero E, Pennet M, Leopold I. Pseudomonas cepacia endophthalmitis. Ann Ophthalmol. 1985;17:753-6.
17. Pathengay A, Raju B, Sharma S, et al. Endophthalmitis Research Group. Recurrent endophthalmitis caused by Burkholderia cepacia. Eye. 2005; 19:358-9.
18. Aaron SD, Ferris W, Henry DA, et al. Multiple combination bactericidal antibiotic testing in cystic fibrosis patients infected with Burkholderia cepacia. Am J Respir Crit Care Med. 2000;161:1206-12.
19. Saika T, Kobayashi I, Hasegawa M, et al. Antimicrobial resistance and DMA-fingerprint pattern of Burkholderia cepacia blood isolates. J Infect Chemother. 2002;8:341-4.
20. Nzula S, Vandamme P, Govan JRW. Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother. 2002;50:265-9.